There has been controversy around aducanumab, which targets the cause rather than the symptoms.
admin, , TOP STORIES, 0
Related Articles
Why getting more EVs on the road is all about charging
But a person can only eat so much fast food—if my journey had been much longer and I needed...
The Download: alternative aviation fuels, and drone-delivered bubble tea
June 2020 Venture capitalists sell themselves as the top of the heap in Silicon Valley. They are the talent...
The chip patterning machines that will shape computing’s next act
Lathrop had spent years looking through microscopes to make something small look bigger. As he puzzled over how to...
A new storage technique could vastly expand the number of livers available for transplant
“In the US, 70% of are not used. Whether we can rescue that 70%, I don’t know,” Clavien...
Love or immortality: A short story
They are two graduate students—Sophie in her sixth and final year, Martin in his fourth—who have traveled from different...
AI professors are negotiating the new realities of academic research
It’s a weird time for university AI researchers, who make up most of the AI2050 group. In the past...
